Patient Guide: A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 203 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07221357
Status: 🟢 Enrolling Now
Condition: Untreated, Unresectable, or Metastatic Colorectal Cancer
Phase: PHASE2, PHASE3

Find a Study Location Near You

This study is available at 203 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Los Angeles, California
  • • Orange, California
  • • San Francisco, California
  • • And 200 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer - Join Clinical Trial NCTNCT07221357

How to Join This Clinical Trial - NCTNCT07221357

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Untreated, Unresectable, or Metastatic Colorectal Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Untreated, Unresectable, or Metastatic Colorectal Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Untreated, Unresectable, or Metastatic Colorectal Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07221357 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 203 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90033 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Orange, California 92868 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

San Francisco, California 94115 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Santa Monica, California 90404 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Stanford, California 94305 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Cape Coral, Florida 33990 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

St. Petersburg, Florida 33705 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Tampa, Florida 33612 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Duluth, Georgia 30096 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Marietta, Georgia 30060 - United States

Status: NOT_YET_RECRUITING

And 193 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for Untreated, Unresectable, or Metastatic Colorectal Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation